Literature DB >> 25294252

CD44 deficiency leads to decreased proinflammatory cytokine production in lung induced by PCV2 in mice.

Qiang Fu1, Linbing Hou1, Pingping Xiao1, Chunhe Guo1, Yaosheng Chen1, Xiaohong Liu2.   

Abstract

Porcine circovirus type 2 (PCV2) is the primary etiological agent of postweaning multisystemic wasting syndrome (PMWS). CD44 is a widely expressed class I transmembrane glycoprotein implicated in immunological and inflammatory responses. In previous studies, the role of CD44 in host defense against microorganism infection remains controversial. The role of CD44 in host defense against PCV2 infection has never been studied before. In this study, we investigated the role of CD44 in the development of pneumonia induced by PCV2 in mice model. Upon infection, CD44 mRNA level in lung tissue was upregulated, and we confirmed a detrimental role of CD44 in host defense against PCV2 infection. The results demonstrated that CD44 deficiency could result in decreased proinflammatory cytokine production in lung induced by PCV2 in mice, suggesting a previously unrecognized role for CD44 in the development of pneumonia response to PCV2 infection.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD44; Pneumonia; Porcine circovirus type 2

Mesh:

Substances:

Year:  2014        PMID: 25294252     DOI: 10.1016/j.rvsc.2014.09.012

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

Review 1.  Interactions of porcine circovirus 2 with its hosts.

Authors:  Linzhu Ren; Xinrong Chen; Hongsheng Ouyang
Journal:  Virus Genes       Date:  2016-03-25       Impact factor: 2.332

2.  Protective effect of diallyl trisulfide against naphthalene-induced oxidative stress and inflammatory damage in mice.

Authors:  Fang Zhang; Yongchun Zhang; Kaiming Wang; Guangpu Liu; Min Yang; Zhongxi Zhao; Shanzhong Li; Jianhua Cai; Jimin Cao
Journal:  Int J Immunopathol Pharmacol       Date:  2016-01-26       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.